GHK-Cu is not in the weight loss peptide category
Some risks of compounded semaglutide include dosing errors (which can lead to serious side effects), contamination, and illegal sales of counterfeit products, which could be harmful
Given retatrutide's potency, extremely conservative dosing would be warranted: Start with minimum doses of both compounds Extend escalation intervals to 6-8 weeks per step Monitor for enhanced metabolic effects and potential hypoglycemia Adjust based on individual metabolic response For those researching advanced peptide protocols, these combination approaches illustrate the complexity and potential of multi-pathway interventions
We exclusively source our peptides from FDA-registered 503A/503B facilities to guarantee absolute purity, potency, and safety
Nat Rev Dis Primers (2018) 4:18001
We are committed to long-term, responsible business practices that deliver financial, social and environmental value